![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
N Tindberg, HA Baldwin, AJ Cross and M Ingelman-Sundberg
Department of Medical Biochemistry and Biophysics, Karolinska institute, Stockholm, Sweden.
Hepatic cytochromes P450 are known to be down-regulated by cytokines, lipopolysaccharide, Gram-positive bacteria, and viruses. Little is known, however, about the regulation by inflammation of cytochromes P450 in other tissues. We have found that lipopolysaccharide and interleukin-1 beta stimulate the expression of catalytically active CYP2E1 (but not CYP1A1 or CYP2B) up to 7-fold in rat brain primary cortical glial cultures. The induction reached a maximum after 24 hr and was accompanied by an increase in CYP2E1 mRNA. Chlormethiazole, a specific inhibitor of hepatic CYP2E1 transcription, completely inhibited the induction of CYP2E1 at the mRNA and enzyme levels. Immunofluorescence studies showed CYP2E1 to be expressed in a subset of astrocytes in the lipopolysaccharide-stimulated cortical glial cultures. Using a model of global ischemic injury in the gerbil, we found CYP2E1 to be induced in vivo in astrocytes in the inflammatory phase, 1-3 weeks after the lesion. Likewise, CYP2E1 was induced in the rat cortex 1 week after a focal ischemic injury. Our results suggest tissue-specific regulation of CYP2E1 by inflammatory factors and that CYP2E1 may play a role in astrocytes during inflammation in the brain.
This article has been cited by other articles:
|
|
 |
|
  J. Michaud, J. Naud, J. Chouinard, F. Desy, F. A. Leblond, K. Desbiens, A. Bonnardeaux, and V. Pichette Role of Parathyroid Hormone in the Downregulation of Liver Cytochrome P450 in Chronic Renal Failure J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3041 - 3048. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Liu, R. F. Frye, R. A. Branch, R. Venkataramanan, J. J. Fung, and G. J. Burckart Effect of Age and Postoperative Time on Cytochrome P450 Enzyme Activity Following Liver Transplantation J. Clin. Pharmacol., June 1, 2005; 45(6): 666 - 673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kelicen and N. Tindberg Lipopolysaccharide Induces CYP2E1 in Astrocytes through MAP Kinase Kinase-3 and C/EBP{beta} and -{delta} J. Biol. Chem., April 16, 2004; 279(16): 15734 - 15742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Nicholson and K. W. Renton The Role of Cytokines in the Depression of CYP1A Activity Using Cultured Astrocytes as an in Vitro Model of Inflammation in the Central Nervous System Drug Metab. Dispos., January 1, 2002; 30(1): 42 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. T. Morgan Regulation of Cytochrome P450 by Inflammatory Mediators: Why and How? Drug Metab. Dispos., March 1, 2001; 29(3): 207 - 212. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. W. Renton and T. E. Nicholson Hepatic and Central Nervous System Cytochrome P450 Are Down-Regulated during Lipopolysaccharide-Evoked Localized Inflammation in Brain J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 524 - 530. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. Hu, M. Oscarson, I. Johansson, Q.-Y. Yue, M.-L. Dahl, M. Tabone, S. Arinco, E. Albano, and M. Ingelman-Sundberg Genetic Polymorphism of Human CYP2E1: Characterization of Two Variant Alleles Mol. Pharmacol., March 1, 1997; 51(3): 370 - 376. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
